US Broker Ratings

Akero Therapeutics, Inc. (AKRO) Investor Outlook: Evaluating a Promising Biotech with a 3.39% Upside Potential

For investors eyeing opportunities in the healthcare sector, particularly within the biotechnology industry, Akero Therapeutics, Inc. (NASDAQ: AKRO) presents an intriguing proposition. With a market capitalization of $4.5 billion, Akero..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating Opportunities with a 12% Potential Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a stalwart in the healthcare sector and a leading player in the medical devices industry, offers intriguing investment prospects as it stands poised at..

Guardant Health, Inc. (GH)

❌ Error generating article: Server error: `POST https://api.openai.com/v1/chat/completions` resulted in a `502 Bad Gateway` response: 502 Bad Gateway 502 Bad Gateway clou (truncated…)

..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Exploring a 25.58% Potential Upside in the Biotech Sector

Cytokinetics, Incorporated (NASDAQ: CYTK), a leading player in the biotechnology sector, has been making waves with its innovative approach to muscle activators and inhibitors. Headquartered in South San Francisco, California,..

TransMedics Group, Inc. (TMDX) Stock Analysis: Exploring the 14% Upside Potential in the Revolutionary Organ Transplant Market

TransMedics Group, Inc. (NASDAQ: TMDX) is making waves in the healthcare sector, particularly within the medical devices industry, with its innovative approach to organ transplantation. The company, with a market..

West Pharmaceutical Services, Inc. (WST) Stock Analysis: Capturing a 29% Upside in the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a prominent player in the healthcare industry, particularly within the medical instruments and supplies sector. With a market capitalization of $19.25 billion,..

Exelixis, Inc. (EXEL) Stock Analysis: Unveiling a 9.94% Potential Upside in the Biotech Marvel

Exelixis, Inc. (NASDAQ: EXEL) is stirring interest among investors with its promising position in the healthcare sector, specifically within the biotechnology industry. Headquartered in Alameda, California, Exelixis is dedicated to..

Tenet Healthcare Corporation (THC) Stock Analysis: Exploring an 18.62% Potential Upside

Tenet Healthcare Corporation (NYSE: THC), a prominent player in the healthcare sector, is currently garnering significant attention from investors. With a market capitalization of $17.62 billion, Tenet operates a diversified..

Vaxcyte, Inc. (PCVX) Stock Analysis: Unveiling a 106.74% Upside Potential in Biotech Innovation

Vaxcyte, Inc. (PCVX), a notable player in the biotechnology sector, has been capturing attention with its innovative approach to vaccine development. Based in San Carlos, California, Vaxcyte specializes in creating..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Challenges with a 23.20% Revenue Growth

Oscar Health, Inc. (NYSE: OSCR), a healthcare technology company based in New York, stands as a unique player in the healthcare plans sector. Despite facing a challenging market environment, Oscar..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A 27% Upside Potential Beckons Investors

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, offers a compelling opportunity for investors with its significant upside potential. Based in Dublin, Ireland, Jazz Pharmaceuticals is..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating Volatility with a 52-Week High of $78

Regencell Bioscience Holdings Limited (RGC), a Hong Kong-based healthcare entity, has captured investors’ attention with its intriguing journey in the realm of Traditional Chinese Medicine (TCM). Specializing in the niche..

Krystal Biotech, Inc. (KRYS)

⚠️ No article content returned.

..

Waystar Holding Corp. (WAY) Stock Analysis: A 49% Potential Upside in Healthcare Technology

Waystar Holding Corp. (NASDAQ: WAY) has been capturing attention in the healthcare technology sector with its innovative cloud-based payment solutions. Founded in 2017 and headquartered in Lehi, Utah, Waystar focuses..

AptarGroup, Inc. (ATR) Stock Analysis: Strong Buy Ratings with 32.90% Potential Upside

AptarGroup, Inc. (NYSE: ATR), a prominent player in the healthcare sector, has caught the attention of investors with its strong buy ratings and significant potential upside. The company, with a..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A Promising 65.97% Upside Potential Awaits Investors

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands out in the biotechnology sector with its commitment to developing therapies for rare and life-threatening diseases. With a market capitalization of $10.24 billion, this..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Assessing the 12.94% Upside Potential

Bio-Rad Laboratories, Inc. (NYSE: BIO), a stalwart in the medical devices industry, is a key player in the healthcare sector. Headquartered in Hercules, California, this company has been at the..

United Therapeutics Corporation (UTHR) Stock Analysis: Navigating Potential with a 4.91% Upside

United Therapeutics Corporation (NASDAQ: UTHR) presents a compelling case for investors with its robust market position in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered..

DaVita Inc. (DVA) Stock Analysis: Insights into a 19% Potential Upside for Healthcare Investors

DaVita Inc. (NYSE: DVA), a leading provider of kidney dialysis services in the United States, is catching the eye of investors with its notable potential upside. Currently trading at $121.35,..

Henry Schein, Inc. (HSIC) Investor Outlook: Navigating Growth Opportunities in Healthcare Distribution

Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the healthcare sector, has carved a niche in the medical distribution industry. With a market capitalization of $9.28 billion, the company stands..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds